Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Aaron Schwartz

Sports Medicine Portland, OR Medical Doctor

NPI 1922398973 CMS profile 1388352

5050 Ne Hoyt St Ste 138, Portland, OR 97213

Open in the dashboard

General payments

$7,778

58 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aaron Schwartz of Portland, OR is reported in the CMS Open Payments database as having received $7,778 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 51st percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,050 8
2024 General $3,336 17
2023 General $1,924 19
2022 General $1,468 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aaron Schwartz
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Aaron Schwartz were reported at $1,050. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Aaron Schwartz Sports Medicine median Middle half National median
2019 $0 $1,176 $199–$4,249 $163
2020 $0 $708 $96–$2,890 $114
2021 $0 $1,213 $152–$3,994 $132
2022 $1,468 $1,230 $159–$3,998 $149
2023 $1,924 $584 $146–$2,836 $160
2024 $3,336 $628 $163–$3,168 $164
2025 $1,050 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Arthrex, Inc. $2,776 27 payments
  2. Steelhead Surgical Inc $2,576 10 payments
  3. Stryker Corporation $1,235 12 payments
  4. Left Coast Surgical Inc $974 5 payments
  5. Smith+Nephew, Inc. $130 2 payments
  6. DePuy Synthes Sales Inc. $58 1 payment
  7. Vertex Pharmaceuticals Incorporated $29 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $4,962 18 payments
  2. Food and Beverage $2,815 40 payments
Products named General payments · program years 2022–2025
  1. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $1,082 10 payments
  2. AEQUALIS PERFORM REVERSED $130 1 payment
  3. K-15 PORK $111 1 payment
  4. KNEE & HIP IMPLANTS MENISCAL REPAIR FIBERSTITCH $81 1 payment
  5. NA Orthopedics $58 1 payment
  6. NA Trauma $58 1 payment
  7. JOURNAVX $29 1 payment
  8. NA Arthroscopy $23 1 payment
  9. INSPACE $23 1 payment
  10. REAL INTELLIGENCE $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

109

Median for Sports Medicine: 144

Drug cost

$691

Median for Sports Medicine: $1,027

Branded share of claims

16.5%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 44 $219
Oxycodone Hcl Generic 36 $215
Ondansetron Odt Ondansetron Brand 18 $180
Ondansetron Hcl Generic 11 $77

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$36,285

Of which drugs: $164

Medicare patients

110

Average age 70

Services billed

491

51 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 53%
Depression 21%
Diabetes 18%
Ischemic heart disease 18%
Osteoporosis 18%
Atrial fibrillation 16%
Chronic kidney disease 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 38 208 $164

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record